Kite Pharma, Inc. Insider Trading for October 2015

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Kite Pharma, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of insider trading in Kite Pharma, Inc. for October 2015.

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 28 2015	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	COO and CFO	Option Exercise	M	1.35	10,000	13,500	365,394
Oct 28 2015	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	COO and CFO	Sell	S	71.01	500	35,505	75,507	76 K to 75.5 K (-0.66 %)
Oct 28 2015	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	COO and CFO	Sell	S	70.23	4,400	309,012	76,007	80.4 K to 76 K (-5.47 %)
Oct 28 2015	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	COO and CFO	Sell	S	69.53	5,100	354,603	80,407	85.5 K to 80.4 K (-5.96 %)
Oct 28 2015	KITE	Kite Pharma, Inc.	BUTITTA CYNTHIA M	COO and CFO	Buy	M	1.35	10,000	13,500	85,507	75.5 K to 85.5 K (+13.24 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Sproule Rizwana F	VP Regulatory Affai ...	Option Exercise	M	1.35	9,567	12,915	142,598
Oct 19 2015	KITE	Kite Pharma, Inc.	Sproule Rizwana F	VP Regulatory Affai ...	Sell	S	64.08	878	56,262	2,941	3.8 K to 2.9 K (-22.99 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Sproule Rizwana F	VP Regulatory Affai ...	Sell	S	63.32	2,475	156,717	3,819	6.3 K to 3.8 K (-39.32 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Sproule Rizwana F	VP Regulatory Affai ...	Sell	S	62.41	4,377	273,169	6,294	10.7 K to 6.3 K (-41.02 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Sproule Rizwana F	VP Regulatory Affai ...	Sell	S	61.54	1,442	88,741	10,671	12.1 K to 10.7 K (-11.90 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Sproule Rizwana F	VP Regulatory Affai ...	Sell	S	60.36	395	23,842	12,113	12.5 K to 12.1 K (-3.16 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Sproule Rizwana F	VP Regulatory Affai ...	Buy	M	1.35	9,567	12,915	12,508	2.9 K to 12.5 K (+325.30 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Option Exercise	M	6.89	9,000	62,010	121,000
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	64.19	465	29,848	6,342	6.8 K to 6.3 K (-6.83 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	63.50	2,007	127,445	6,807	8.8 K to 6.8 K (-22.77 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	62.54	4,702	294,063	8,814	13.5 K to 8.8 K (-34.79 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	61.61	1,375	84,714	13,516	14.9 K to 13.5 K (-9.23 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Sell	S	60.42	451	27,249	14,891	15.3 K to 14.9 K (-2.94 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Wiezorek Jeffrey	SVP Clinical Develo ...	Buy	M	6.89	9,000	62,010	15,342	6.3 K to 15.3 K (+141.91 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Roberts Margo R	Chief Scientific Of ...	Option Exercise	M	17.00	645	10,965	34,523
Oct 19 2015	KITE	Kite Pharma, Inc.	Roberts Margo R	Chief Scientific Of ...	Option Exercise	M	0.70	5,500	3,850	107,625
Oct 19 2015	KITE	Kite Pharma, Inc.	Roberts Margo R	Chief Scientific Of ...	Sell	S	64.25	84	5,397	2,198	2.3 K to 2.2 K (-3.68 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Roberts Margo R	Chief Scientific Of ...	Sell	S	63.60	1,600	101,760	2,282	3.9 K to 2.3 K (-41.22 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Roberts Margo R	Chief Scientific Of ...	Sell	S	62.62	2,800	175,336	3,882	6.7 K to 3.9 K (-41.90 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Roberts Margo R	Chief Scientific Of ...	Sell	S	61.79	1,300	80,327	6,682	8 K to 6.7 K (-16.29 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Roberts Margo R	Chief Scientific Of ...	Sell	S	60.08	361	21,689	7,982	8.3 K to 8 K (-4.33 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Roberts Margo R	Chief Scientific Of ...	Buy	M	17.00	645	10,965	8,343	7.7 K to 8.3 K (+8.38 %)
Oct 19 2015	KITE	Kite Pharma, Inc.	Roberts Margo R	Chief Scientific Of ...	Buy	M	0.70	5,500	3,850	7,698	2.2 K to 7.7 K (+250.23 %)
Oct 02 2015	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Option Exercise	M	6.89	7,700	53,053	261,500
Oct 02 2015	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Sell	S	55.11	7,700	424,347	6,904	14.6 K to 6.9 K (-52.73 %)
Oct 02 2015	KITE	Kite Pharma, Inc.	Chang David D	EVP, R&D, Chief Med ...	Buy	M	6.89	7,700	53,053	14,604	6.9 K to 14.6 K (+111.53 %)
Oct 02 2015	KITE	Kite Pharma, Inc.	Better Marc	VP, Product Science ...	Option Exercise	M	0.38	9,000	3,420	96,000
Oct 02 2015	KITE	Kite Pharma, Inc.	Better Marc	VP, Product Science ...	Sell	S	57.10	74	4,225	1,888	2 K to 1.9 K (-3.77 %)
Oct 02 2015	KITE	Kite Pharma, Inc.	Better Marc	VP, Product Science ...	Sell	S	56.43	1,454	82,049	1,962	3.4 K to 2 K (-42.56 %)
Oct 02 2015	KITE	Kite Pharma, Inc.	Better Marc	VP, Product Science ...	Sell	S	55.37	1,263	69,932	3,416	4.7 K to 3.4 K (-26.99 %)
Oct 02 2015	KITE	Kite Pharma, Inc.	Better Marc	VP, Product Science ...	Sell	S	54.47	5,079	276,653	4,679	9.8 K to 4.7 K (-52.05 %)
Oct 02 2015	KITE	Kite Pharma, Inc.	Better Marc	VP, Product Science ...	Sell	S	53.51	1,130	60,466	9,758	10.9 K to 9.8 K (-10.38 %)
Oct 02 2015	KITE	Kite Pharma, Inc.	Better Marc	VP, Product Science ...	Buy	M	0.38	9,000	3,420	10,888	1.9 K to 10.9 K (+476.69 %)